Filing Details

Accession Number:
0001415889-25-021025
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-08-05 16:07:52
Reporting Period:
2025-08-01
Filing Date:
2025-08-05
Accepted Time:
2025-08-05 16:07:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1894562 Prime Medicine Inc. PRME Services-Computer Programming, Data Processing, Etc. (7370) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1652044 Alphabet Inc. 1600 Amphitheatre Parkway
Mountain View CA 94043
No No Yes No
1861202 Gv 2021, L.p. 1600 Amphitheatre Parkway
Mountain View CA 94043
No No Yes No
1861206 Gv 2021 Gp, L.l.c. 1600 Amphitheatre Parkway
Mountain View CA 94043
No No No No
1861216 Gv 2021 Gp, L.p. 1600 Amphitheatre Parkway
Mountain View CA 94043
No No Yes No
Transaction Summary
Purchased: 1,500,000 shares Avg. Price: $3.30 Total Value: $4,950,000.00
Number of Shares After Transactions: 3,262,440 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-08-01 1,500,000 $3.30 3,262,440 No 4 P Indirect By GV 2021, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By GV 2021, L.P.
Footnotes
  1. Represents shares purchased in connection with an underwritten public offering of the Issuer's Common Stock that closed on August 1, 2025.
  2. The securities reported in this row are directly beneficially owned by GV 2021, L.P. (the "2021 Partnership"). The general partner of the 2021 Partnership is GV 2021 GP, L.P. (the "2021 GP"). The general partner of the 2021 GP is GV 2021 GP, L.L.C. ("GV 2021 LLC"). The sole member of GV 2021 LLC is Alphabet Holdings LLC ("Alphabet Holdings"). The sole member of Alphabet Holdings is XXVI Holdings Inc. ("XXVI"). The controlling stockholder of XXVI is Alphabet Inc. Each of the 2021 GP, GV 2021 LLC, Alphabet Holdings, XXVI, and Alphabet Inc. may be deemed to indirectly beneficially own (as the term is defined in Rule 13d-3 of the Securities Exchange Act of 1934, as amended) the securities directly beneficially owned by the 2021 Partnership. Each of the aforementioned parties disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.